Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 20, 2024
The
aim
is
to
provide
new
insights
for
researchers
studying
the
pathogenesis
of
diabetic
cognitive
dysfunction
and
promoting
wider
use
natural
products
in
their
treatment.
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: Feb. 7, 2025
Mitochondrial
dysfunction
is
a
pivotal
instigator
of
neuroinflammation,
with
mitochondrial
DNA
(mtDNA)
leakage
as
critical
intermediary.
This
review
delineates
the
intricate
pathways
leading
to
mtDNA
release,
which
include
membrane
permeabilization,
vesicular
trafficking,
disruption
homeostatic
regulation,
and
abnormalities
in
dynamics.
The
escaped
activates
cytosolic
sensors,
especially
cyclic
gmp-amp
synthase
(cGAS)
signalling
inflammasome,
initiating
neuroinflammatory
cascades
via
pathways,
exacerbating
spectrum
neurological
pathologies.
therapeutic
promise
targeting
discussed
detail,
underscoring
necessity
for
multifaceted
strategy
that
encompasses
preservation
homeostasis,
prevention
leakage,
reestablishment
dynamics,
inhibition
activation
sensors.
Advancing
our
understanding
complex
interplay
between
neuroinflammation
imperative
developing
precision
interventions
disorders.
Environment International,
Journal Year:
2024,
Volume and Issue:
188, P. 108771 - 108771
Published: May 22, 2024
Microcystins
(MCs)
and
nitrites
are
coexisted
in
the
environment
have
reproductive
toxicity.
The
combined
toxic
effect
mechanism
of
MCs
nitrite
on
spermatogenesis
remain
largely
unclear.
In
present
study,
co-exposure
to
microcystin-leucine
arginine
(MC-LR)
sodium
(NaNO2)
aggravated
testicular
damage
Balb/c
mice
mitochondrial
impairment
spermatogonia,
Sertoli
cells,
sperm.
Furthermore,
MC-LR
NaNO2
reduced
sperm
density
with
a
synergistic
effect.
addition,
synergistically
induced
oxidative
stress
system
by
decreasing
superoxide
dismutase
(SOD)
activity
glutathione
(GSH)
levels
increasing
reactive
oxygen
species
(mtROS)
(ROS).
More
importantly,
mitoquidone
mesylate
(MitoQ),
an
inhibitor
mtROS,
blocked
NaNO2-induced
spermatogonia
cell
apoptosis
inhibiting
high
expression
Bax,
Fadd,
Caspase-8,
cleaved-Caspase-3.
On
other
hand,
MitoQ
suppressed
pyroptosis
cells
NLRP3,
N-GSDMD,
cleaved-Caspase-1.
Additionally,
alleviated
co-exposure-induced
reduction
organ
index
disorders
F1
generation
mice.
Together,
can
enhance
spermatogenic
impairment-mediated
germ
death.
This
study
emphasizes
potential
risks
reproduction
realistic
environments
highlights
new
insights
into
cause
treatment
disorders.
Free Radical Biology and Medicine,
Journal Year:
2024,
Volume and Issue:
222, P. 211 - 222
Published: June 20, 2024
Oxygen
is
essential
for
aerobic
life
on
earth
but
it
also
the
origin
of
harmful
reactive
oxygen
species
(ROS).
Ubiquinone
par
excellence
endogenous
cellular
antioxidant,
a
very
hydrophobic
one.
Because
that,
other
molecules
have
been
envisaged,
such
as
idebenone
(IDE)
and
mitoquinone
(MTQ),
having
same
redox
active
benzoquinone
moiety
higher
solubility.
We
used
molecular
dynamics
to
determine
location
interaction
these
molecules,
both
in
their
oxidized
reduced
forms,
with
membrane
lipids
similar
that
mitochondria.
Both
IDE
(IDOL)
are
situated
near
interface,
whereas
MTQ
(MTQOL)
locate
position
adjacent
phospholipid
hydrocarbon
chains.
The
quinone
moieties
ubiquinone
10
(UQ10)
UQ10
(UQOL10)
contraposition
IDE,
IDOL,
MTQOL,
located
interphase,
isoprenoid
chains
remained
at
middle
These
do
not
aggregate
functional
different
depths
whereby
protecting
them
from
ROS
effects.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
AbstractBackground:
Neuropathic
pain
has
been
shown
to
induce
abnormal
mitochondrial
fission
in
neurons,
yet
the
analgesic
potential
of
inhibiting
this
process
remains
unclear.
Our
previous
studies
demonstrated
that
targeted
regulation
dynamin-related
protein
(DRP1)
can
alleviate
neuropathic
pain;
however,
downstream
molecular
signaling
mechanisms
remain
be
elucidated.
Methods:
To
investigate
role
dynamics
pain,
we
utilized
C57BL/6J
mice,
GAD2-Cre
and
vGluT2-Cre
mice.
Mitochondrial
network
changes
states
were
assessed
using
GAD2-MITO
vGluT2-MITO
transgenic
mouse
models
combined
with
MiNA
analysis.
Pain
thresholds
expression
levels
various
molecules
spinal
dorsal
horn
(SDH)
evaluated
through
behavioral
tests,
immunofluorescence,
Western
blotting.
morphology
function
conditions
examined
electron
microscopy,
membrane
potential,
reactive
oxygen
species,
adenosine
triphosphate
assays.
The
effects
antioxidant
analgesics
epigallocatechin
gallate
(EGCG)
Cinnamic
Acid
on
SDH
during
also
investigated.
Results:
We
observed
networks
both
excitatory
inhibitory
neurons
disrupted
spared
nerve
injury
as
evidenced
by
models.
Specifically,
down-regulating
FIS1
but
not
within
elicited
effects,
experiments
conducted
Additionally,
(EGCG),
which
effectively
down-regulates
SDH,
concurrently
inhibited
SNI-induced
pain.
These
findings
suggest
reducing
fragmentation
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 6, 2025
Abstract
Although
neuropathic
pain
leads
to
abnormal
mitochondrial
fission
in
neurons,
it
remains
unclear
whether
inhibiting
has
analgesic
effects.
This
study
focused
on
protein
1
(FIS1)
investigate
its
role
spared
nerve
injury
(SNI)-induced
and
the
underlying
mechanisms.
Using
MiNA
analysis,
electron
microscopy,
membrane
potential
(MMP),
reactive
oxygen
species
(ROS),
adenosine
triphosphate
(ATP)
detection,
we
observed
that
networks
both
excitatory
inhibitory
neurons
of
spinal
dorsal
horn
(SDH)
were
disrupted
SNI
mice,
as
demonstrated
through
use
specifically
constructed
GAD2-MITO
vGluT2-MITO
transgenic
mouse
models.
Furthermore,
down-regulating
FIS1
but
not
could
exert
effects,
using
vGluT2-Cre
mice
GAD2-Cre
mice.
Third,
epigallocatechin
gallate
(EGCG),
which
was
capable
horn,
concurrently
inhibited
SNI-induced
pain.
The
above
results
indicate
SDH
can
alleviate
by
reducing
fragmentation.
In
addition,
improving
dysfunction.
Our
research
findings
suggest
may
represent
a
novel
molecular
target
for
treatment